Related Experiment Video
Updated: Sep 27, 2025

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
Published on: June 24, 2020
Interventions for Infection and Inflammation-Induced Preterm Birth: a Preclinical Systematic Review
Faith A Miller1, Adalina Sacco1, Anna L David1,2
1Elizabeth Garrett Anderson Institute for Women's Health, University College London, 86-96 Chenies Mews, London, WC1E 6HX, UK.
Insights
Promising anti-inflammatory interventions show potential for preventing preterm birth in animal models. Further research requires standardized models to improve clinical translation for infection-induced premature births.
Area of Science:
- Reproductive Biology
- Immunology
- Pharmacology
Background:
- Spontaneous preterm birth (before 37 weeks gestation) is often linked to infection and inflammation.
- Current treatments for infection-related preterm birth are limited, necessitating the development of new therapeutic strategies.
- Animal models are crucial for pre-clinical research into potential interventions.
Approach:
- A PROSPERO-registered preclinical systematic review following PRISMA guidelines.
- Searched PubMed, EMBASE, and Web of Science for studies on animal models, preterm birth, inflammation, and therapeutics.
- Included 23 quantitative, peer-reviewed, controlled studies using prenatal interventions in animal models.
Key Points:
- Twenty-four interventions were evaluated, primarily in mouse models using lipopolysaccharide or Escherichia coli to induce preterm birth.
- Eighty-three percent of interventions significantly prolonged gestational length, and 87% reduced maternal inflammation markers.
- Interventions targeting interleukin-1, interleukin-6, and toll-like receptors demonstrated significant therapeutic potential.
Conclusions:
- Interventions targeting inflammation show significant therapeutic promise for preventing preterm birth in preclinical models.
- Standardization of preterm birth models (infectious agent, dose, timing, outcomes) is critical for reproducibility and clinical translation.
- Further research is needed to refine these interventions and facilitate their move to clinical application.
Abstract:
Spontaneous preterm births (< 37 weeks gestation) are frequently associated with infection. Current treatment options are limited but new therapeutic interventions are being developed in animal models. In this PROSPERO-registered preclinical systematic review, we aimed to summarise promising interventions for infection/inflammation-induced preterm birth. Following PRISMA guidance, we searched PubMed, EMBASE, and Web of Science using the themes: "animal models", "preterm birth", "inflammation", and "therapeutics". We included original quantitative, peer-reviewed, and controlled studies applying prenatal interventions to prevent infection/inflammation-induced preterm birth in animal models. We employed two risk of bias tools. Of 4020 identified studies, 23 studies (24 interventions) met our inclusion criteria. All studies used mouse models. Preterm birth was most commonly induced by lipopolysaccharide (18 studies) or Escherichia coli (4 studies). Models varied according to infectious agent serotype, dose, and route of delivery. Gestational length was significantly prolonged in 20/24 interventions (83%) and markers of maternal inflammation were reduced in 20/23 interventions (87%). Interventions targeting interleukin-1, interleukin-6, and toll-like receptors show particular therapeutic potential. However, due to the heterogeneity of the methodology of the included studies, meta-analysis was impossible. All studies were assigned an unclear risk of bias using the SYRCLE risk of bias tool. Interventions targeting inflammation demonstrate therapeutic potential for the prevention of preterm birth. However, better standardisation of preterm birth models, including the dose, serotype, timing of administration and pathogenicity of infectious agent, and outcome reporting is urgently required to improve the reproducibility of preclinical studies, allow meaningful comparison of intervention efficacy, and aid clinical translation.
More Related Videos
09:36Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
Published on: July 28, 2022
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...